Sanofi Said Unwilling to Meet Both Genzyme Demands

Sanofi Said Unwilling to Meet Both Genzyme Demands

Antoine Antoniol/Bloomberg

Sanofi, France’s biggest pharmaceutical company, must decide this week whether to extend its hostile tender offer at $69 a share, raise the bid, or walk away if it doesn’t win support from enough Genzyme shareholders.